Quick Answer
Outlook Therapeutics, Inc. reported Common Stock Shares Outstanding of 53.89 million shares for the year ending 2025.
- Outlook Therapeutics, Inc. showed an increase of +125.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Outlook Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Outlook Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 471.1%.
- Historical annual values: Fiscal year 2025: 53.89 million shares | Fiscal year 2024: 23.91 million shares | Fiscal year 2023: 13.01 million shares | Fiscal year 2022: 227.31 million shares | Fiscal year 2021: 176.46 million shares | Fiscal year 2020: 127.18 million shares | Fiscal year 2019: 28.61 million shares | Fiscal year 2018: 9.03 million shares | Fiscal year 2017: 24.93 million shares | Fiscal year 2016: 22.80 million shares | Fiscal year 2015: 9.44 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: